HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 511 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,884,975 | +2.3% | 932,535 | -9.1% | 0.33% | +2.8% |
Q2 2023 | $105,477,818 | +19.0% | 1,025,550 | +26.2% | 0.32% | +3.2% |
Q1 2023 | $88,663,262 | +19.7% | 812,381 | +24.8% | 0.32% | +18.4% |
Q4 2022 | $74,087,214 | +225.4% | 651,030 | +77.0% | 0.27% | +150.9% |
Q3 2022 | $22,769,000 | +167.8% | 367,891 | +245.1% | 0.11% | +194.4% |
Q2 2022 | $8,503,000 | +758.9% | 106,606 | +1033.0% | 0.04% | +1100.0% |
Q1 2022 | $990,000 | -81.5% | 9,409 | -81.1% | 0.00% | -82.4% |
Q4 2021 | $5,365,000 | +492.8% | 49,783 | +503.0% | 0.02% | +466.7% |
Q3 2021 | $905,000 | -68.5% | 8,256 | -73.1% | 0.00% | -70.0% |
Q2 2021 | $2,872,000 | -11.0% | 30,667 | -12.5% | 0.01% | -28.6% |
Q1 2021 | $3,226,000 | +30.2% | 35,055 | +3.5% | 0.01% | +27.3% |
Q4 2020 | $2,478,000 | -51.7% | 33,867 | -48.7% | 0.01% | -45.0% |
Q3 2020 | $5,128,000 | +1092.6% | 66,017 | +753.4% | 0.02% | +900.0% |
Q2 2020 | $430,000 | -88.3% | 7,736 | -93.8% | 0.00% | -91.7% |
Q1 2020 | $3,682,000 | -60.8% | 124,334 | -52.1% | 0.02% | -22.6% |
Q4 2019 | $9,388,000 | +74.4% | 259,337 | +31.2% | 0.03% | +55.0% |
Q3 2019 | $5,383,000 | +0.9% | 197,674 | -10.9% | 0.02% | +5.3% |
Q2 2019 | $5,336,000 | – | 221,769 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |